SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
_________
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
March 15, 1996
___________________________________
Date of report (Date of earliest event reported)
CHURCHILL TECHNOLOGY, INC.
________________________________________________________
(Exact Name of Registrant as Specified in its Charter)
Colorado 0-11372 84-0904172
_________________________________________________________________
_____________
(State or Other Jurisdiction (Commission (IRS Employer
of Incorporation) File Number) Identification No.)
181 Cooper Avenue, Tonawanda, New York 14150
_________________________________________________________________
_____________
(Address of Principle Executive Offices) (Zip Code)
Registrant's telephone number, including area code (716)874-8699
_______________
Former Name or Former Address, if Changed Since Last Report
_________________________________________________________________
_____________
<PAGE>
Item 5. Other Events
On March 19, 1996, the Company announced that it has entered into
an agreement with Fima Capital Corporation to issue up to 50
million shares of common stock. As set forth more fully in the
press release, attached hereto and incorporated herein by
reference, the Company has taken steps to secure funding to
provide sufficient working capital to support the production and
sale of Novon products.
Item 7. Financial Statements and Exhibits
(c) Exhibits:
10.1 Agreement by and between, the Registrant and FIMA
Capital Corporation Ltd., dated March 15, 1996.
99.1 Press Release dated March 19, 1996.
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, as amended, the Registrant has duly caused this report to
be signed on its behalf by the undersigned hereunto duly
authorized.
CHURCHILL TECHNOLOGY, INC.
March 20, 1996 By: /s/ Bertha Mitchell
________________________________
Bertha Mitchell, Vice President,
Treasurer,Secretary and Chief
Financial Officer
Exhibit 10.1
AGREEMENT
_________
This Agreement is signed this 15th day of March 1996 by and
between, Churchill Technology Inc. ("Churchill" or the "Company")
and FIMA Capital Corporation Ltd. (FCC)
1. In accordance with the Resolution by Unanimous Consent
ratified by the Board of Directors of Churchill of the 7th of
March 1996, Churchill will:
1.1 Issue up to 50,000,000 new shares of common stock.(New
Stock).
1.2 In consideration of the recent price fluctuations in
the market price of the company's common stock and the high risk
involved in the investment due to the precarity of the financial
position of the Company the minimum sale price of the New Stock
shall be 5 cts. per share (the "Issue Price").
2. Churchill undertakes to issue the New Stock as follows:
2.1 5,000,000 shares shall be made available to the
employees and officers of the Company via an Employee Stock
Programme that Churchill will put in place in accordance with the
appropriate regulatory and statutory requirements. The persons
eligible to purchase these shares shall have the option to
purchase these shares at the Issue Price at any time during the
75 days following the signature of this Agreement.
2.2 31,000,000 shares shall be issued to FCC for placement
with its investors.
2.3 14,000,000 shares shall be placed with an investment
group introduced by FCC.
3. FCC will place 11,000,000 of the shares issued as per 2.2
above immediately with specifically identified investors for
payment on or before the 29th of March 1996.
4. FCC will employ its best endeavours to place the balance of
20,000,000 shares of New Stock with its private investors at
a price not less than 5 cts. per share. Such placement to be
completed within 60 days from the date of the public announcement
of the signature of this Agreement.
5. FCC may, at its option, purchase at the Issue Price part or
all of the New Stock in 4 above for its own account, before the
expiry of the limit date specified in 4 above.
6. If at the limit date specified in 4 above FCC has not been
able to place the entire amount of the New Stock issued as per 4
above and has not already exercised its right to purchase such
New Stock then FCC undertakes to purchase and pay for, at the
Issue Price, all shares of the New Stock remaining unplaced or
unsold on the limit date as specified in 4 above.
<PAGE>
7. All payments in respect of the purchase of the New Stock
shall be effected by wire transfer or certified cheque to
Churchill as directed at the time of settlement.
8. FCC may at its sole discretion effect payment at the Issue
Price for up to 4,000,000 of the shares specified in 4 above by
the conversion of its current loan of US $ 200,000 to Churchill.
9. FCC may, in agreement with the consent of the lender, effect
payment at the Issue Price for a further 2,800,000 of the New
Stock specified in 4 above by the conversion of loans made to the
Company by other Directors of the Company. New Stock for which
payment is effected in this manner shall be issued to the lender
whose loan is converted.
10. Churchill undertakes to use the funds arising from the issue
of the New Stock as follows:
10.1 The purchase of an income stream arising from licences
granted for the use of the Novonr patents.
10.2 The balance for general financing requirements.
11. The Agreement is construed in accordance with the laws of
the State of New York.
12. This Agreement is the complete Agreement between the parties
hereto and supersedes, annuls and replaces all other agreements,
verbal or written, between the parties hereto and which may be
relative to the issue of the New Stock.
In witness of the Agreements and covenants herein contained the
parties hereto set their hands to this Agreement on the date
first mentioned above:
Mr. Robert H. Downie Mr. Gamal Marwan
Chairman, President & CEO President
Churchill Technology Inc. FIMA Capital Corporation Ltd.
Ms. Bertha Mitchell
Chief Financial Officer
Churchill Technology Inc.
Exhibit 99.1
TO BUSINESS EDITOR:
CHURCHILL TECHNOLOGY INC. TO RAISE $2.5 MILLION;
COMPANY WILL ISSUE UP TO 50 MILLION SHARES
Buffalo, N.Y., March 19 /PRNewswire/ -- Churchill Technology Inc.
(Nasdaq: CHUR) today announced that it has entered into an agreement
with Fima Capital Corporation to issue up to 50 million shares of
common stock at a minimum price of $.05 per share. Fima Capital
Corporation is a British Virgin Islands Corporation which owned 7.6
percent of Churchill prior to this transaction, and which is
beneficially owned by Gamal Marwan, a Director of Churchill.
The agreement calls initially for the issuance of 30 million
shares. Robert H. Downie, Churchill president and chief executive
officer, and Dr. Ashraf Marwan are the major investors of the first
tranche of the financing. Dr. Marwan is Gamal Marwan's father. Five
million of the shares will be made available to the employees and
officers of the Company and of Novon International Inc. via an Employee
Stock Purchase Plan that will be put in place in accordance with the
appropriate regulatory requirements. The remaining 20 million shares
will be taken up by Fima and a group of investors within 60 days.
"We have been searching, without success, for debt and quasi-debt
financing for several months," said Downie.
"We believe this capital injection will sufficiently strengthen
our balance sheet, giving us access to more conventional debt markets
over the next few months. The funding will help our new Novonr product
line get off to a good start, by providing sufficient working capital
to support the production and sale of these materials. We are
optimistic about the sales prospects of our Novonr products over the
coming months, based on the interest that has been expressed since the
announcement of its availability. This capital injection will also
help us acquire assets which we believe are key to the future of our
Company," said Downie.
In a related announcement, Churchill confirmed that it has issued
11 million shares to the original Novon shareholders in accordance with
the Novon Acquisition Agreement signed in February 1994.
Churchill Technology Inc. is the parent company of Novon
International, Inc., a leader in the development and production of
specialty additives and resins that safely make plastics biodegradable.
The company's products are marketed as Novonr Specialty Polymers,
Degra-Novonr, and Aqua-Novonr.
Novon International, Inc. is a growth-stage company whose products
include additive packages, specialty polymers, and water-soluble
materials that are used in packaging, composting, agricultural, food
service, and personal care applications.
-0- 3/19/96
/CONTACT: Ken Houseknecht of Crowley Webb Public Relations, 716-
856-2932/
(CHUR)